Cemex, S.A.B. de C.V. Sponsored (CX) Stock Price & How to Invest

Cemex (NYSE: CX) is a global building-materials company that makes and sells cement, ready-mix concrete, and aggregates (crushed stone, sand, and gravel), along with related urbanization and infrastructure products. It operates across five reportable segments (Mexico, the United States, Europe, the Middle East and Africa, and South, Central America and the Caribbean), with the US and Mexico together accounting for roughly 60% of 2025 revenue. The US-listed security is an ADR representing the underlying Mexican shares; the company is one of the largest cement producers in the world alongside Holcim, Heidelberg Materials, and CRH.

The investment picture centers on a cyclical, capital-intensive business tied to construction and infrastructure spending, layered with company-specific self-help. Over 2024 and 2025 Cemex pushed pricing discipline and its company-wide efficiency program, cut net debt toward roughly $5.0 billion, and reshaped its portfolio by exiting smaller markets (Guatemala, the Philippines, the Dominican Republic, most of Panama) while redeploying capital into US aggregates through acquisitions such as Couch Aggregates. Results into 2026 showed record quarterly EBITDA and expanding margins: second-quarter 2026 revenue reached about $4.59 billion, adjusted sales grew about 11%, EBITDA topped $1 billion (including a $42 million one-off settlement in Europe), and free cash flow from operations hit a record $651 million, but the stock remains sensitive to interest rates, US and Mexican construction activity, foreign-exchange swings, and energy input costs. Net debt rose about $270 million in the first half of 2026 as acquisitions, buybacks and dividends outran cash generation, leaving net financial leverage at about 2.08x.

Cemex is a deeply cyclical business whose demand swings with construction and infrastructure spending, so a downturn or higher-for-longer interest rates could pressure volumes and pricing. As a Mexico-based operator with an ADR listing, it carries meaningful emerging-market and foreign-exchange risk, with most debt in dollars but large revenue in pesos and other currencies. Energy and fuel costs are a major input and can compress margins, and the company recorded goodwill impairments and asset write-downs (about $538 million in 2025). Regulatory, carbon-emission, and geopolitical exposure across its Middle East, Africa, and Latin American footprint add further uncertainty, and the elevated trailing P/E (about 85 as of October 2026, inflated by a fourth-quarter 2025 loss) leaves little room for execution missteps. In July 2026 the European Commission said construction companies and trade bodies had likely formed a pricing cartel, a regulatory overhang for the European building-materials industry that Cemex operates in. The stock's roughly 19% drop over the three months to mid-October 2026 shows how quickly sentiment can turn even after a beat-and-raise quarter.

15 analysts publish price targets on CX, averaging $14.68 against a $10.25 price as of October 2026, or +43.2%. The published targets run from $11.00 to $20.00, a moderate spread, and the ratings split 12 buy, 3 hold, 0 sell. Over the last six months there have been 5 raises and 2 cuts among the published actions. A price target is what an analyst published on a date, not a prediction, and sell-side ratings skew positive across the whole market.

Read the full CX forecast and price target for the target table, the recent rating actions by firm, and how the consensus has shifted.

We give no verdict on Cemex, S.A.B. de C.V. Sponsored. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.

The case for buying. US aggregates and infrastructure tilt. Cemex has been redeploying proceeds from smaller-market exits into US aggregates (for example the Couch Aggregates acquisition), shifting the mix toward higher-margin, longer-life materials. The most optimistic published target, $20.00, assumes this works close to its best case.

The case against. Cemex is a deeply cyclical business whose demand swings with construction and infrastructure spending, so a downturn or higher-for-longer interest rates could pressure volumes and pricing. The most pessimistic target, $11.00, is roughly what CX is worth if this bites instead.

Read the full bull and bear case on CX, including what would have to change to break either one. Walnut is not an investment adviser.

Yes. Cemex, S.A.B. de C.V. Sponsored (CX) has had one share split in the last 10 years:

• 104:100 on May 3, 2017, so every share held became 1.04 shares.

A split changes the share count and the price per share and leaves the value of a holding unchanged. Someone holding $1,000 of CX the day before the 104:100 split held $1,000 the day after, in more shares at a proportionally lower price. Historical prices from before the date are normally shown split-adjusted, which is why a long-run chart shows no cliff.

Splits matter mainly because they make older price figures confusing to compare by hand, and because a board choosing to split is usually signalling that the price has run up far enough to feel awkward for smaller buyers. Neither is a reason to buy or sell.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see Cemex, S.A.B. de C.V. Sponsored's investor relations page or your broker.

• Revenue (TTM): ~$17.0B (Q2 2026 +12% YoY)
• Q2 2026 revenue: ~$4.59B
• Q2 2026 EBITDA: above $1B; adjusted margin ~21.4%
• Net income (TTM): ~$513M (Q2 2026 ~$347M)
• Net financial leverage: ~2.08x (June 2026)
• P/E (trailing / forward): ~85 / ~11
• Dividend yield: ~1.2%
• Market cap: ~$14.8B

Cemex trades around $10.26 per ADR with a trailing P/E near 85, inflated by a fourth-quarter 2025 net loss, but a forward P/E near 11 and an EV/EBITDA of about 6.5, which point to expectations of rising earnings as efficiency programs and US aggregates flow through. The forward multiple has compressed since July because the share price fell about 19% in three months while guidance went up. Consensus for the October 26 third-quarter report is EPS near $0.21 on revenue near $4.43 billion.

Other names that sit close to CX: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. Worth a look if you are thinking about diversification within a thesis rather than concentration on one ticker.

There are three common ways to get CX exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic portfolio, so CX sits alongside other stocks that express the same thesis.

Walnut takes the portfolio route. Describe a thesis where CX fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

Cemex is a large, real building-materials operator whose story is a leveraged bet on North American and Mexican construction demand, margin self-help, and continued debt reduction. Operations improved through mid-2026, with second-quarter EBITDA above $1 billion and full-year EBITDA growth guidance raised to 16% to 17%, yet the shares fell after the summer; third-quarter results are due October 26, 2026.

Whether CX is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is CX a buy or a sell?, and where the stock could go from here in the CX stock forecast.

For income investors, whether CX pays a dividend and how the payout looks is covered in does CX pay a dividend? And to weigh CX against a peer, read the full side-by-side comparisons: CX vs CRH and CX vs VMC.